6533b86ffe1ef96bd12ce888

RESEARCH PRODUCT

The Role of Interleukin 10 in the Regulation of Allergic Immune Responses

Iris BellinghausenJoachim SalogaJürgen Knop

subject

Hypersensitivity ImmediateAllergyT-Lymphocytesmedicine.medical_treatmentT cellImmunologyImmunoglobulin EImmune toleranceAtopyImmune systemHumansImmunology and AllergyMedicineClonal Anergybiologybusiness.industryDendritic CellsGeneral MedicineImmunotherapymedicine.diseaseInterleukin-10Interleukin 10medicine.anatomical_structureDesensitization ImmunologicImmunologybiology.proteinbusiness

description

Several clinical studies and animal models have shown that Th2 lymphocytes play a key role in the pathophysiology of IgE-mediated allergic immune responses like allergic rhinitis and asthma or venom anaphylaxis. Classical specific immunotherapy (SIT) that has been proven to be clinically effective can serve as a role model for immunological changes that are associated with amelioration of allergic diseases. During SIT, the Th2-dominated immune response is modified towards a Th1 response leading to a decline in allergen-specific IgE and an increase in allergen-specific IgG production. Most importantly, however, production of the immunosuppressive/-regulatory cytokine interleukin 10 (IL-10) is also induced leading to T cell tolerance and prevention of tissue inflammation. In this article the role of IL-10-producing T cells in the regulation of allergic immune responses will be discussed.

https://doi.org/10.1159/000049499